ImmunoPrecise Antibodies Ltd.
General ticker "IPA" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $34.4M (TTM average)
ImmunoPrecise Antibodies Ltd. follows the US Stock Market performance with the rate: 47.4%.
Estimated limits based on current volatility of 5.1%: low 1.61$, high 1.78$
Factors to consider:
- Total employees count: 79 as of 2025
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-04-30 to 2027-04-30
- 2025-04-30 to 2026-04-30 estimated range: [0.28$, 0.93$]
- 2026-04-30 to 2027-04-30 estimated range: [0.34$, 1.04$]
Short-term IPA quotes
Long-term IPA plot with estimates
Financial data
| YTD | 2023-04-30 | 2024-04-30 | 2025-04-30 |
|---|---|---|---|
| Operating Revenue | CA$20.66MM | CA$24.52MM | CA$24.52MM |
| Operating Expenses | CA$46.28MM | CA$38.28MM | CA$36.72MM |
| Operating Income | CA$-25.61MM | CA$-13.76MM | CA$-12.20MM |
| Non-Operating Income | CA$-2.14MM | CA$-14.94MM | CA$-22.07MM |
| Interest Expense | CA$0.03MM | CA$0.02MM | CA$0.29MM |
| R&D Expense | CA$14.11MM | CA$4.06MM | CA$4.94MM |
| Income(Loss) | CA$-27.75MM | CA$-28.70MM | CA$-34.27MM |
| Taxes | CA$-1.19MM | CA$-1.53MM | CA$-4.03MM |
| Profit(Loss)* | CA$-26.56MM | CA$-27.18MM | CA$-30.23MM |
| Stockholders Equity | CA$57.80MM | CA$33.92MM | CA$23.63MM |
| Inventory | CA$2.06MM | CA$2.14MM | CA$2.10MM |
| Assets | CA$77.81MM | CA$59.99MM | CA$44.44MM |
| Operating Cash Flow | CA$-19.83MM | CA$-4.25MM | CA$-6.41MM |
| Capital expenditure | CA$1.50MM | CA$1.40MM | CA$0.80MM |
| Investing Cash Flow | CA$-1.97MM | CA$-1.56MM | CA$-0.80MM |
| Financing Cash Flow | CA$-0.62MM | CA$1.02MM | CA$14.89MM |
| Earnings Per Share** | CA$-1.07 | CA$-1.06 | CA$-0.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.